David A. Socks

Business address
C/O Cadence Pharmaceuticals, Inc., 12481 High Bluff Drive, Suite 200, San Diego, CA, 92130
Top holdings (ownership)
HLVX and PHAT
Get insider transactions for this reporting owner
David A. Socks has filed 42 SEC EDGAR filings since 24 Oct 2006

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 24 May 2024 23 May 2024 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 30 May 2023 25 May 2023 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 27 May 2022 25 May 2022 001-39094
3 Open Document Open Filing FORM 3 SUBMISSION 28 Apr 2022 28 Apr 2022 001-41365
4 Open Document Open Filing FORM 4 SUBMISSION 08 Oct 2021 07 Oct 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 23 Sep 2021 21 Sep 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 18 Aug 2021 16 Aug 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 29 Jun 2021 28 Jun 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 24 May 2021 21 May 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 21 May 2021 19 May 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 07 Apr 2021 05 Apr 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 12 Mar 2021 10 Mar 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 23 Feb 2021 19 Feb 2021 001-39094
5 Open Document Open Filing FORM 5 SUBMISSION 12 Feb 2021 01 Dec 2020 001-39094
SC 13G/A Open Document Open Filing SC 13G/A 11 Feb 2021
4 Open Document Open Filing FORM 4 SUBMISSION 13 Jan 2021 11 Jan 2021 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 18 Dec 2020 16 Dec 2020 001-39094
4 Open Document Open Filing FORM 4 SUBMISSION 12 Nov 2020 09 Nov 2020 001-39094
SC 13G Open Document Open Filing SC 13G 10 Feb 2020
3 Open Document Open Filing FORM 3 SUBMISSION 24 Oct 2019 24 Oct 2019 001-39094